Explain this page
Arphra AIPlain-English read on Madrigal Pharmaceuticals, Inc.’s valuation06-10today
- 3 Under-the-Radar Stocks to Buy and Hold for a Decade8d
- Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript13d
- Madrigal (MDGL) Down 7.9% Since Last Earnings Report: Can It Rebound?18d
- Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates49d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $656.00 (+27.77%)
Candlestick · 1Y
Open in chart workstation →MDGL
505.75+77.47%H 615.00L 277.64MA50 509.79MA200 493.39Avg vol 346K
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.11% | +0.04% | -0.74% | +15.37% | -14.83% | -11.83% | +80.16% | +118.28% | +407.59% | +4632.07% | +61.38% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$504.01
Bid
$480.00
1 sh
Ask
$525.00
1 sh
Spread
$45.000
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Real Estate+1.01%
- Consumer Cyclical+0.94%
- Energy+0.84%
- Consumer Defensive+0.82%
- Financial Services+0.23%
- Basic Materials-0.11%
- Healthcare-0.18%
- Communication Services-0.18%
- Industrials-0.47%
- Technology-0.85%
- Utilities-1.03%
Top industries (issuer's industry highlighted)
- Biotechnology+3.28%
- Software - Services+9.60%
- Broadcasting+8.34%
- Travel Services+7.87%
- Computer Hardware+4.56%
- Oil & Gas Energy-3.54%
- Electrical Equipment & Parts-3.26%
- Semiconductors-2.12%
- Communication Equipment+2.06%
- REIT - Healthcare Facilities+2.01%
- Drug Manufacturers - Specialty & Generic+1.99%
- Consulting Services-1.97%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- 3 Under-the-Radar Stocks to Buy and Hold for a Decadefool.com·Jun 16, 2026
- Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 10, 2026
- Madrigal (MDGL) Down 7.9% Since Last Earnings Report: Can It Rebound?zacks.com·Jun 05, 2026
- Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updatesglobenewswire.com·May 06, 2026
Recent analyst activity
DB- Jun 11, 2026GradeNeutral → NeutralMadrigal Pharmaceuticals (MDGL) PT Lowered to $542 at BofA SecuritiesBank of America Securities
- Jun 11, 2026PT$542.00Madrigal Pharmaceuticals (MDGL) PT Lowered to $542 at BofA SecuritiesMorgan Stanley
Financial scores
DBJun 24, 2026Altman Z
8.73
Safe
≥ 3.0 safe · 1.81–3.0 grey · < 1.81 distress
Piotroski F
2/9
Weak
≥ 7 strong · 4–6 average · < 4 weak
Peers
No peer list available for MDGL.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|